HRP20120106T1 - Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima - Google Patents
Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima Download PDFInfo
- Publication number
- HRP20120106T1 HRP20120106T1 HR20120106T HRP20120106T HRP20120106T1 HR P20120106 T1 HRP20120106 T1 HR P20120106T1 HR 20120106 T HR20120106 T HR 20120106T HR P20120106 T HRP20120106 T HR P20120106T HR P20120106 T1 HRP20120106 T1 HR P20120106T1
- Authority
- HR
- Croatia
- Prior art keywords
- capsule
- entacapone
- mill
- sugar alcohols
- following
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN264MU2008 | 2008-02-06 | ||
| PCT/IB2009/050490 WO2009098663A1 (en) | 2008-02-06 | 2009-02-06 | Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120106T1 true HRP20120106T1 (hr) | 2012-02-29 |
Family
ID=40626966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20120106T HRP20120106T1 (hr) | 2008-02-06 | 2009-02-06 | Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8728517B2 (es) |
| EP (1) | EP2293791B1 (es) |
| JP (1) | JP5651478B2 (es) |
| KR (1) | KR101532810B1 (es) |
| CN (1) | CN101939002B (es) |
| AT (1) | ATE534382T1 (es) |
| AU (1) | AU2009211030B2 (es) |
| BR (1) | BRPI0907727A2 (es) |
| CA (1) | CA2714113C (es) |
| CY (1) | CY1116484T1 (es) |
| DK (1) | DK2293791T3 (es) |
| ES (1) | ES2377597T3 (es) |
| HR (1) | HRP20120106T1 (es) |
| MX (1) | MX2010008707A (es) |
| NZ (1) | NZ587169A (es) |
| PL (1) | PL2293791T3 (es) |
| PT (1) | PT2293791E (es) |
| RU (1) | RU2010136934A (es) |
| SI (1) | SI2293791T1 (es) |
| WO (1) | WO2009098663A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010023828A1 (de) * | 2010-06-15 | 2011-12-15 | IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH | Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält |
| CN106880607A (zh) * | 2015-12-15 | 2017-06-23 | 北大方正集团有限公司 | 一种含有瑞戈非尼的口腔崩解片及其制备方法 |
| CN115715767B (zh) * | 2022-11-02 | 2023-06-09 | 石家庄四药有限公司 | 一种恩他卡朋片剂的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2642486B2 (ja) * | 1989-08-04 | 1997-08-20 | 田辺製薬株式会社 | 難溶性薬物の超微粒子化法 |
| US6599530B2 (en) | 1998-09-14 | 2003-07-29 | Orion Corporation | Oral compacted composition comprising catechol derivatives |
| FI109453B (fi) * | 1999-06-30 | 2002-08-15 | Orion Yhtymae Oyj | Farmaseuttinen koostumus |
| WO2006131591A2 (en) * | 2005-06-08 | 2006-12-14 | Orion Corporation | An entacapone-containing oral dosage form |
| GB2429645A (en) * | 2006-03-10 | 2007-03-07 | Sekhsaria Chemicals Ltd | Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent |
-
2009
- 2009-02-06 RU RU2010136934/15A patent/RU2010136934A/ru not_active Application Discontinuation
- 2009-02-06 NZ NZ587169A patent/NZ587169A/en not_active IP Right Cessation
- 2009-02-06 SI SI200930145T patent/SI2293791T1/sl unknown
- 2009-02-06 MX MX2010008707A patent/MX2010008707A/es active IP Right Grant
- 2009-02-06 PL PL09708991T patent/PL2293791T3/pl unknown
- 2009-02-06 KR KR1020107019493A patent/KR101532810B1/ko not_active Expired - Fee Related
- 2009-02-06 PT PT09708991T patent/PT2293791E/pt unknown
- 2009-02-06 CN CN2009801045469A patent/CN101939002B/zh not_active Expired - Fee Related
- 2009-02-06 DK DK09708991.6T patent/DK2293791T3/da active
- 2009-02-06 EP EP09708991A patent/EP2293791B1/en not_active Not-in-force
- 2009-02-06 AU AU2009211030A patent/AU2009211030B2/en not_active Ceased
- 2009-02-06 ES ES09708991T patent/ES2377597T3/es active Active
- 2009-02-06 HR HR20120106T patent/HRP20120106T1/hr unknown
- 2009-02-06 CA CA2714113A patent/CA2714113C/en not_active Expired - Fee Related
- 2009-02-06 US US12/865,783 patent/US8728517B2/en not_active Expired - Fee Related
- 2009-02-06 BR BRPI0907727A patent/BRPI0907727A2/pt not_active IP Right Cessation
- 2009-02-06 WO PCT/IB2009/050490 patent/WO2009098663A1/en not_active Ceased
- 2009-02-06 AT AT09708991T patent/ATE534382T1/de active
- 2009-02-06 JP JP2010545597A patent/JP5651478B2/ja not_active Expired - Fee Related
-
2012
- 2012-01-17 CY CY20121100050T patent/CY1116484T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009098663A1 (en) | 2009-08-13 |
| DK2293791T3 (da) | 2012-02-13 |
| ATE534382T1 (de) | 2011-12-15 |
| JP5651478B2 (ja) | 2015-01-14 |
| KR20100117096A (ko) | 2010-11-02 |
| CY1116484T1 (el) | 2017-03-15 |
| CA2714113C (en) | 2015-11-24 |
| JP2011526241A (ja) | 2011-10-06 |
| US20110052681A1 (en) | 2011-03-03 |
| RU2010136934A (ru) | 2012-03-20 |
| CN101939002A (zh) | 2011-01-05 |
| CA2714113A1 (en) | 2009-08-13 |
| AU2009211030A1 (en) | 2009-08-13 |
| EP2293791B1 (en) | 2011-11-23 |
| SI2293791T1 (sl) | 2012-03-30 |
| US8728517B2 (en) | 2014-05-20 |
| EP2293791A1 (en) | 2011-03-16 |
| BRPI0907727A2 (pt) | 2017-06-13 |
| MX2010008707A (es) | 2011-03-25 |
| AU2009211030B2 (en) | 2013-12-05 |
| NZ587169A (en) | 2011-03-31 |
| PL2293791T3 (pl) | 2012-04-30 |
| PT2293791E (pt) | 2012-01-11 |
| CN101939002B (zh) | 2012-12-26 |
| KR101532810B1 (ko) | 2015-06-30 |
| ES2377597T3 (es) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4707073B2 (ja) | アトルバスタチン経口投与用粒子状医薬組成物 | |
| ES2699806T3 (es) | Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata | |
| CN101896167B (zh) | 药物组合物 | |
| JP2015166379A5 (es) | ||
| JP6081436B2 (ja) | ヒドロキシアルキルセルロース微粒子 | |
| RU2010136935A (ru) | Фармацевтические композиции энтакапона, леводопы и карбидопы с улучшенной биодоступностью | |
| EP2647648B1 (en) | Solid dosage form containing a low viscosity HYDROXYALKYL CELLULOSE | |
| CN102631347A (zh) | 一种吉非替尼药物组合物及其制备方法 | |
| WO2013122134A1 (ja) | 経口投与用医薬組成物 | |
| JP2009502807A5 (es) | ||
| JP5367735B2 (ja) | 錠剤の製造方法 | |
| CA3207801A1 (en) | Oily suspensions of microparticulate isotretinoin with improved oral bioavailability | |
| HRP20120106T1 (hr) | Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima | |
| RU2012131951A (ru) | Фармацевтическая композиция, содержащая частицы реина или диацереина и способ ее получения | |
| JP2009173603A (ja) | 漢方薬およびパンテチン類を含有する錠剤 | |
| CN102626410A (zh) | 一种含有罗氟司特的药物组合物 | |
| JP5365949B2 (ja) | 低用量ラモセトロン含有口腔内崩壊錠 | |
| CN104000821B (zh) | 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法 | |
| CN111743902A (zh) | 一种包含微粉化形式的口服固体药物组合物及其制备方法 | |
| CN1895535A (zh) | 用于治疗咽喉疾病的中药制剂及其生产方法 | |
| CN104027316B (zh) | 一种格列美脲片剂及其制备方法 | |
| CN105435144A (zh) | 一种生姜微丸及其制备方法 | |
| JP2013087170A (ja) | ヒドロキシプロピルセルロース微粒子 | |
| JPWO2014157603A1 (ja) | 経口投与用医薬組成物 | |
| WO2006101462A3 (en) | Pharmaceutical preparation comprising perindopril erbumine and method of preparation and stabilisation thereof |